Key Viral Hepatitis Studies Influencing My Practice Following AASLD 2021
Listen to expert insights from Nancy Reau, MD, on updates and new viral hepatitis data from AASLD 2021, including HBV treatment in pregnancy, outcomes following HBV treatment withdrawal, progress toward HBV cure, HCV implementation science and the cascade of care, characterization of the population with hepatitis delta, and phase III clinical trial updates for hepatitis delta.
Decera Clinical Education Infectious Disease Podcast · Nancy Reau MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Nancy Reau, MD, discusses new viral hepatitis data from AASLD 2021, including:
- HBV treatment in pregnancy
- Outcomes following HBV treatment withdrawal
- Progress toward an HBV cure
- HCV implementation science and current status of the cascade of care
- Hepatitis delta virus: understanding the clinical impact
- Phase III clinical trial updates for hepatitis delta virus, including data on bulevirtide
Presenter:
Nancy Reau, MD
Professor of Medicine
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Richard B. Capps Chair of Hepatology
Rush University Medical Center
Chicago, Illinois
Follow along with the downloadable slideset at:
https://bit.ly/3d6NQRV
Link to full program:
https://bit.ly/3lputrT
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.